Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732847 | SCV000860840 | benign | not specified | 2018-04-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000952352 | SCV001098849 | likely benign | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001672948 | SCV001889763 | benign | not provided | 2020-04-21 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000732847 | SCV002071566 | benign | not specified | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001672948 | SCV004145229 | benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | PIK3R2: BS1, BS2 |
Breakthrough Genomics, |
RCV001672948 | SCV005210778 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003918216 | SCV004744667 | benign | PIK3R2-related disorder | 2019-09-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |